Biotricity, Inc.BTCYNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P38
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -5.11% |
| Q3 2025 | 7.77% |
| Q2 2025 | -34.42% |
| Q1 2025 | 36.92% |
| Q4 2024 | 5.91% |
| Q3 2024 | -24.18% |
| Q2 2024 | -35.64% |
| Q1 2024 | 53.78% |
| Q4 2023 | -14.07% |
| Q3 2023 | -0.93% |
| Q2 2023 | 14.31% |
| Q1 2023 | -35.54% |
| Q4 2022 | 6.63% |
| Q3 2022 | -0.27% |
| Q2 2022 | -24.17% |
| Q1 2022 | 27.15% |
| Q4 2021 | -17.93% |
| Q3 2021 | 58.44% |
| Q2 2021 | 14.46% |
| Q1 2021 | -6.21% |
| Q4 2020 | 28.80% |
| Q3 2020 | -18.88% |
| Q2 2020 | -19.47% |
| Q1 2020 | 82.01% |
| Q4 2019 | 7.85% |
| Q3 2019 | -1.52% |
| Q2 2019 | 42.25% |
| Q1 2019 | -22.47% |
| Q4 2018 | -8.16% |
| Q3 2018 | -4.78% |
| Q2 2018 | -0.34% |
| Q1 2018 | 24.33% |
| Q4 2017 | 64.96% |
| Q3 2017 | -2.38% |
| Q2 2017 | -14.92% |
| Q1 2017 | -32.55% |
| Q4 2016 | 60.91% |
| Q3 2016 | 116.12% |
| Q2 2016 | 59.49% |
| Q1 2016 | -71.72% |